Cumberland Pharmaceuticals Inc. (CPIX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Cumberland Pharmaceutical... (CPIX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.71

0.38 (16.31%)

At close: Jan 14, 2025, 3:59 PM

2.41

-11.07%

After-hours Jan 14, 2025, 07:59 PM EST

undefined% (undefined)

Bid	2.41
Market Cap	38.05M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.76
PE Ratio (ttm)	-3.57
Forward PE	n/a
Analyst	n/a

Ask	2.43
Volume	7,354,080
Avg. Volume (20D)	1,880,075
Open	2.30
Previous Close	2.33
Day's Range	2.29 - 3.65
52-Week Range	1.04 - 3.65
Beta	undefined

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxat...

[Show more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

IPO Date Aug 11, 2009

Employees 91

Stock Exchange NASDAQ

Ticker Symbol CPIX

Website https://www.cumberlandpharma.com

Why Price Moved

1 month ago · Source

+0%

Cumberland Pharmaceuticals shares are trading high... Unlock content with Pro Subscription

News

1 month ago · benzinga.com

Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?

On Monday, the FDA approved Cumberland Pharmaceuticals Inc's CPIX supplemental New Drug Application (sNDA) for its Acetadote (N-acetylcysteine for injection) product.

2 months ago · seekingalpha.com

Cumberland Pharmaceuticals Inc. (CPIX) Q3 2024 Earnings Call Transcript

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Molly Aggas - Investor Relations, Dalton Agency A.J. Kazimi - Chief Exe...